The issue is not whether ACIP includes mRNA-1345 on its agenda (it surely will if MRNA-1345 receives FDA approval), but rather what ACIP's recommendation will be. The CDC almost always rubber-stamps whatever ACIP recommends, which then becomes the standard practice of most US healthcare providers.